Dow Down1.10% Nasdaq Down1.82%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
0.88 Up 0.01(1.01%) Feb 8, 4:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingOct 31, 2015Jul 31, 2015Apr 30, 2015Jan 31, 2015
Total Revenue 9,523   9,671   9,308   5,677  
Cost of Revenue4,741  4,608  4,758  3,113  
Gross Profit 4,782   5,063   4,550   2,564  
Operating Expenses
Research Development14,190  13,918  11,531  11,261  
Selling General and Administrative4,416  4,899  5,188  4,325  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (13,824) (13,754) (12,169) (13,022)
Income from Continuing Operations
Total Other Income/Expenses Net626  31  34  29  
Earnings Before Interest And Taxes(13,198)(13,723)(12,135)(12,993)
Interest Expense -   -   -  1  
Income Before Tax(13,198)(13,723)(12,135)(12,994)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(13,198)(13,723)(12,135)(12,994)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (13,198) (13,723) (12,135) (12,994)
Preferred Stock And Other Adjustments(1,035)(1,378)(1,119)(775)
Net Income Applicable To Common Shares (14,233) (15,101) (13,254) (13,769)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.